Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate efficacy and safety of inotuzumab ozogamicin in combination with rituximab when used as induction therapy prior to consolidation with HD chemo and aSCT in subjects with relapsed/refractory CD22-positive DLBCL.
Critère d'inclusion
- Diffuse large B-cell Non-Hodgkin's lymphoma (DLBCL)